ALNY vs OOMA · P/E 76, rev $1.29B vs P/E 52, rev $83.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Ooma Inc (OOMA) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Ooma Inc (OOMA) is a software - application company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported OOMA revenue for 2026-07-31 was $83.2M. Net income was $3.0M. Revenue was up 2.6% from 2026-04-30 to 2026-07-31. OOMA currently screens at market cap $468.2M and trailing P/E 51.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. OOMA currently screens at market cap $468.2M and trailing P/E 51.6.
Not investment advice. Open the ALNY and OOMA stock pages for the full models.
Not investment advice.